Announcement: Deep Learning Unlocks Molecular Secrets in Meningioma Diagnosis Without Genetic Testing

Last updated: 24/08/2026 07:29

0 Min Read

A new study demonstrates that artificial intelligence trained on routine pathology slides can identify meningioma molecular subtypes and predict patient outcomes without expensive genetic testing, potentially democratising precision oncology in resource-limited countries. — Photo by Google DeepMind on Pexels (Pexels License)

1 min read|58 words

Breakthrough: Deep learning can now classify meningiomas by molecular type using only routine pathology slides—eliminating the need for expensive genetic testing. A new study in The Lancet Digital Health shows AI can predict patient outcomes with accuracy matching genomic profiling. This could transform brain tumour care in resource-limited settings worldwide.

Read the full article on GMJ Newsroom →

Was this article helpful?

GMJ Brief · Announcement

📰 Read the full article: Deep Learning Unlocks Molecular Secrets in Meningioma Diagnosis Without Genetic Testing →

Share This Article

ByProf. Giorgi Pkhakadze

Follow:

Prof. Giorgi Pkhakadze, MD, MPH, PhD, is Editor-in-Chief of the Georgian Medical Journal and Chair of the Public Health Institute of Georgia (PHIG). He is Professor and Head of the Department of Social and Behavioural Sciences at David Tvildiani Medical University, and Secretary/Treasurer of the UEMS Section of Public Health. ORCID: 0000-0001-7609-4515.